Figure 1From: Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE) The NICE study flowchart. The intention-to-treat (ITT).Back to article page